CX5461 is an rRNA synthesis inhibitor with oral activity that inhibits Pol I-driven rRNA transcription. CX5461 activates the DNA damage response and has antitumor activity in tumors such as ovarian cancer.
Molecular Weight:
513.61
Purity:
95.44%
CAS Number:
[1138549-36-6]
Formula:
C27H27N7O2S
Target:
DNA/RNA Synthesis
T2100
* VAT and and shipping costs not included. Errors and price changes excepted